The trademark application XAPLYTA was filed by Intra-Cellular Therapies, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 18, 2017, and it was registered by office on November 27, 2017 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on August 8, 2018. Change of name and professional address of the trademark registration was recorded on September 19, 2018. Appointment and Replacement of representative of the trademark registration was recorded on January 11, 2021.